|
Originally published In Press as doi:10.1074/jbc.M102891200 on May 7, 2001
J. Biol. Chem., Vol. 276, Issue 29, 27188-27196, July 20, 2001
Contributions of the Individual Domains in Human La Protein
to Its RNA 3'-End Binding Activity*
Uta-Maria
Ohndorf ,
Clemens
Steegborn,
Rainer
Knijff, and
Peter
Sondermann
From the Max-Planck-Institut für Biochemie, Abteilung
Strukturforschung, Am Klopferspitz 18a,
D-82152 Planegg-Martinsried, Germany
Received for publication, April 2, 2001
 |
ABSTRACT |
The autoantigen La regulates the maturation of
RNA polymerase III transcripts by binding to their poly(U) termination
signal. The modular protein harbors a N-terminal RNA recognition motif (RRM), RRM1, and in the C-terminal domain, a second, atypical RRM2, in
addition to a phosphorylation site, and a putative nucleotide binding
site. This study presents a detailed investigation into the RNA 3'-end
binding properties of La by using binding titration and competition
assays with subsequent gel mobility shift analysis. Two truncation
mutants containing one (La-RRM1) or both (La-RRM1-RRM2) RNA-binding
domains were constructed, overexpressed, and purified. A
Kd value of 25 ± 10 nM for La
binding to a nonameric RNA ligand with the oligouridylate recognition
sequence was obtained, discriminating with a specificity ratio of
~100 for this probe over a RNA ligand with a 3'-poly(A) stretch. The
N-terminal La-RRM1 region was identified as the major contributor of
these properties to La, manifested in a 5-fold lower
Kd of 5 ± 3 nM and a slightly
increased specificity ratio of 120 for the RNA ligand. The atypical
RRM2 in the C-terminal domain of La has an unprecedented negative
effect on 3'-end RNA recognition, as indicated by a higher Kd value of 90 ± 10 nM for the
La-RRM1-RRM2 mutant but comparable specificity. Thus the C-terminal
regions beyond RRM2 positively modulate the RNA binding affinity of La.
Negative regulation, however, occurs through Ser366
phosphorylation decreasing the binding affinity by 2-fold. ATP had no
influence on RNA complex formation. The functional implications of
these findings for the mechanism of action of La are discussed.
 |
INTRODUCTION |
Human La protein (lupus antigen or
La/SS-B) was originally identified as a major target of the autoimmune
response in patients suffering from the autoimmune diseases
Sjögren's syndrome and systemic lupus erythematosus (1). It is a
conserved RNA-binding protein that recognizes specifically
3'-oligouridylate stretches (2). Associated with all RNA polymerase III
transcripts where the 3'-UUU-OH sequence is added as the transcription
termination signal, La is thought to play a central role in the
metabolism of these RNAs by acting as a molecular chaperone that
stabilizes and/or structures them for further processing (3). In HeLa cell extracts, the 5'- and 3'-end processing of tRNA precursors is
influenced by La (4), and in vitro, La activity has been suggested in RNA polymerase termination, recycling, and initiation reactions (5-8). Furthermore, a Walker A nucleotide-binding motif in
La was postulated to confer ATP-dependent RNA/DNA and
RNA/RNA helicase activity (9, 10), but recently, the binding of La to
double-stranded nucleic acids was shown to be independent of this site,
and La does not appear to unwind double-stranded RNA (11). The Walker A
motif has instead been implicated in binding to the 5'-triphosphate
ends of nascent tRNAs, with the affinity negatively modulated by
phosphorylation of Ser366 (4, 7). Cytoplasmic functions for
La have also been described, including facilitation of translation or
replication of viral RNA and stabilization of histone mRNA (12,
13).
The 46.8-kDa human La antigen is a modular protein (14) and belongs to
the RNA recognition motif
(RRM)1 protein or the
ribonucleoprotein (RNP) superfamily. The RRM motif is an approximately
80-amino acid RNA-binding domain that contains several well conserved
residues. Some of these residues cluster into two short submotifs, the
octameric RNP-1 and the hexameric RNP-2 (15). Several members of the
RNP family involved in single- and double-stranded RNA recognition
carry multiple copies of the RRM in a tandem arrangement (15).
Protease digestion showed that the La protein can be divided in a
N-terminal and a highly charged C-terminal domain connected by a
43-amino acid linker (16). The N terminus is highly conserved and can
be subdivided further in a La protein-specific domain (La motif), amino
acids 16-75 (17), and a RNA-binding motif, RRM1, spanning amino acids
112-184 (18). Most of the autoantigenic epitopes are found in this
domain of the protein with the immunodominant epitopes mapping to RRM1
(19). In contrast, the C-terminal region of the protein seems to have
expanded differentially during evolution. A highly degenerate RNA
recognition domain, RRM2, amino acids 230-294, is present in metazoans
but absent in yeast (20, 21). This domain is fused to several auxiliary
domains involved in RNA binding and functional specialization, such as
a dimerization domain localized within residues 294-348 (22), the
putative ATP-binding motif, amino acids 333-340 (23), the
phosphorylation site at Ser366 (4, 7), and a nuclear
localization signal in the region of amino acids 382-408 (24, 25).
A bipartite binding model correlating the 5'-end binding activity with
the C-terminal part and 3'-end recognition with the N-terminal region
of La has been proposed (26), but to date, no comparative quantitative
study dissecting the contributions of the individual domains to either
of these RNA binding activities has been undertaken.
Kd values for general RNA binding of full-length La
under various assay conditions with different RNA substrates have been
reported, and they range from 37 to 5 nM (27, 28).
Investigations with in vitro translated N- or C-terminal
deletion mutants of La and human Y RNA localized the RNA binding
activity within the N-terminal domain of the antigen (29). Similarly,
the La motif in conjunction with RRM1 and several additional C-terminal
residues were determined to form the minimal structure for high
affinity interaction with tRNA precursors and viral RNAs (27, 28).
Moreover, regions within the C-terminal domain of La, distinct from the
N terminus, may be critical for recognition of the 3'-end (28). In
support of this notion, through immunoprecipitation and filter binding
assays, La phosphorylation primarily occurring at Ser366
was reported to impair poly(U) recognition (30, 31). Furthermore, the
presence of ATP was found to abrogate the 3'-UUU-OH affinity (30). A
systematic examination of the 3'-end binding activity of RRM2, also
localized within the C-terminal domain of La, is lacking. It could
contribute to RNA binding or serve a different function.
To understand the role of the individual RRMs in La, as well as the
C-terminal region outside these motifs, we constructed and purified two
deletion mutants containing one or both RNA-binding units. Our assay
system was designed to investigate the contributions of the individual
protein regions solely to the 3'-end binding affinity of La. The two
parameters, binding affinity and specificity, that characterize the RNA
complex formation were determined by gel mobility shift analysis and
compared with the truncated proteins under identical assay conditions.
Furthermore, the influence of phosphorylation on the binding affinity
of full-length La was studied. The effect of ATP on single-stranded RNA
recognition was also probed in the presence of ATP or the
nonhydrolyzable ATP mimic ATP- -S. We describe how our results relate
to the binding model postulated for the activity of La in the pre-tRNA
maturation pathway (26).
 |
EXPERIMENTAL PROCEDURES |
Materials--
A cDNA encoding the human La antigen in the
pET-8c expression vector was a generous gift of G. J. M. Pruijn (University of Nijmegen, Nijmegen, The Netherlands). The
nonameric RNA sequences 9nt-U, 5'-UGCUGUUUU-3', and 9nt-A,
5'-CCGAAAAAA-3', were synthesized at the Genzentrum
(Ludwig-Maximilian-Universität, Munich, Germany). The
quantitation of radioactively labeled RNA probes was carried out on a
Fuji phosphorus imaging system.
Construction of Plasmid DNA--
DNA fragments encoding the
truncated proteins La-RRM1 (amino acid 1-202) and La-RRM1-RRM2 (amino
acids 10-300) were derived by polymerase chain reaction. The primers
were synthesized on the basis of the published human La sequence (14)
with the addition of an NdeI and a EcoRI
restriction site and cloned into the pET-22b+ vector (Novagen). The
primers used were 5'-AAA AAA ACA TAT GGC TGA AAA TGG TGA TAA TGA AAA
GAT GGC T-3' and 5'-AGA ATT CCT ATT CCA CTT TAT TTT G-3' for the
La-RRM1 mutant and 5'-AAA AAA ACA TAT GGC TGC CCT GG-3' and 5'-AGA ATT
CTC ATT CTT TGT TCC TTA ATT G-3' for the La-RRM1-RRM2 mutant. The
resulting constructs were confirmed by DNA sequencing and used for
recombinant protein production.
Protein Expression and Purification--
The full-length and
truncated La proteins were overproduced in Escherichia coli
BL21 (DE3) plysS (Stratagene). The cells were harvested 3 h after
induction, resuspended in 150 mM NaCl, 0.02% NaN3, 50 mM Tris-HCl, pH 8.0, 5 mM
EDTA, and 10 mg/ml Pefabloc (Roche Molecular Biochemicals), and
sonicated. The lysate was cleared by centrifugation for 20 min at
30,000 × g and 4 °C to yield the supernatant with
the overexpressed soluble protein. This supernatant was filtered
through a 2-µm filter and loaded onto a Resource Q anion exchange
column (Amersham Pharmacia Biotech) on an Äkta fast protein
liquid chromatography system (Amersham Pharmacia Biotech) and eluted
with 0.1 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 0.5 mM dithiothreitol, 25 mM Tris-HCl, pH 8.0 and 9% (v/v) glycerol (buffer A). The
flow through fraction was immediately loaded onto a 5-ml Heparin Hitrap
column (Amersham Pharmacia Biotech) and eluted over 10 column volumes
with a linear gradient from 0.1 to 1 M NaCl in buffer A. The fractions containing the desired protein were pooled, diluted
5-fold, loaded onto a 10-ml poly(U)-Sepharose affinity column (Amersham
Pharmacia Biotech), and eluted over 4 column volumes with the same
gradient. The fractions containing pure recombinant protein were
concentrated in Millipore Ultrafree 5-kDa molecular weight
cut-off filter units. Purity was determined by Coomassie
Blue-stained SDS-PAGE. The protein concentrations were determined from
A280 by using the calculated extinction
coefficients of 40,500 M 1 cm 1
for La, 22,100 M 1 cm 1 for
La-RRM1, and 28,700 M 1 cm 1 for
La-RRM1-RRM2. The purified proteins were stored at 4 °C.
Circular Dichroism Measurements--
All CD studies were
performed on a Jasco J-715 spectrophotometer with a 0.1-cm-pathlength
cuvette. The proteins were diluted to 200 µg/ml in 0.4 mM
Tris/HCl, pH 7.0, and 3 mM NaCl. The measurements were made
at room temperature with a 1-nm bandwidth and 0.1-nm step size. Each
spectrum is the average of eight recordings.
RNA Binding Assays--
The synthetic RNA nonamer 9nt-U was
5'-end-labeled with T4 polynucleotide kinase (New England Biolabs) and
[ -32P]dATP (Amersham Pharmacia Biotech) and purified
on G25 spin columns (Amersham Pharmacia Biotech). For the gel mobility
shift assays 300 ng (5000 cpm) of this RNA substrate were titrated with
90 pM to 7 µM of the respective protein La,
La-RRM1-RRM2, or La-RRM1 in 25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 0.5 mM dithiothreitol, and 0.5%
Nonidet P-40 (buffer B). The influence of a ribonucleotide triphosphate
was probed in the presence of 90 µM ATP (Sigma) or
ATP- -S (Sigma), respectively. The binding reactions were incubated
on ice for 30 min in a total volume of 23 µl. Upon addition of
loading dye (40% sucrose, 0.01% (w/v) xylene cyanol), the solutions
were immediately resolved on a prerun, precooled 9% native
polyacrylamide gel at 4 °C in 0.5× TBE buffer (45 mM
Tris-HCl, 45 mM boric acid, 0.1 mM EDTA). The
gels were run for 1 h at 110 V and then vacuum dried onto Whatman
No. 3MM chromatography paper. The dried gels were exposed to x-ray film and quantitated by phosphorus imaging.
Data Analysis--
For each titration reaction the bands
corresponding to the bound and the unbound probe were quantitated. The
apparent equilibrium dissociation constant (Kd) was
estimated from nonlinear least square fits of binding data to the
Langmuir isotherm (32) using KaleidaGraph 3.5 software, where is
the fraction of bound oligonucleotide probe and P is the
total protein concentration. Each Kd value is the
average of at least two replicates.
|
(Eq. 1)
|
Competition Assays--
Relative dissociation constants for La,
La-RRM1, and La-RRM1-RRM2 were determined in a competition assay. The
full-length protein (27 nM), La-RRM1 (9 nM), or
La-RRM1-RRM2 (270 nM) were incubated for 10 min on ice with
varying concentrations of unlabeled 9nt-U or 9nt-A in a total volume of
22 µl. After addition of 32P-labeled 9nt-U (150 nM), the reaction mixtures were incubated for an additional
10 min to reach equilibrium at concentrations at which 10-80% of the
labeled RNA was bound. The reaction mixtures were resolved by
electrophoresis as described for the gel mobility shift assays.
Phosphorus imaging analysis was used to quantitate the bands
corresponding to bound and unbound probe. The competitive binding of a
protein to the labeled RNA probe and the unlabeled competitor RNA can
be described by Equation 2 (33), where Krel is
the ratio of Kt, the apparent dissociation constant of the labeled probe, to KC, the apparent
dissociation constant of the competitor, and Pt,
Tt, and Ct are the concentrations
of the protein, the radiolabeled probe, and the competitor probe,
respectively. Competition data were fit to Equation 2 by using
KaleidaGraph 3.5 software. The errors were based on the statistical fit
of the data and represent ± S.D. Each data point was determined
in two or three independent experiments.
|
(Eq. 2)
|
In Vitro Phosphorylation/Dephosphorylation Assays--
For the
phosphorylation reactions 2.8 µg of the full-length La protein was
incubated overnight at 30 °C with 500 units of casein kinase II (New
England Biolabs) in the presence of 300 µM ATP in the
buffer supplied by the manufacturer in a total volume of 30 µl.
Similarly, 2.8 µg of La protein were incubated with 5 units of
protein phosphatase 1 (New England Biolabs). As a control for the loss
of RNA binding activity, the same reactions were also carried out in
the absence of those enzymes. Subsequent RNA binding assays were
performed as described above.
Isoelectric Focussing--
Isoelectric focussing was performed
on a Phast system (Amersham Pharmacia Biotech) with Servalyt precotes
gels (Serva) over a pH range of 3-10. The gels were electrophoresed at
2.5 mA for 30 min with a 300 VAh limit. The pI values were deduced by
using the broad pI calibration kit (Amersham Pharmacia Biotech).
Visualization of the proteins was performed by Coomassie Blue staining.
 |
RESULTS |
Construction and Purification of Deletion Mutants of Human La
Protein--
Early studies suggested that La recognizes 3'-terminal
uridylates in RNA (2, 34). Because the full-length La protein contains
two distinct RRM domains designated RRM1 (amino acids 112-184) and
RRM2 (amino acids 230-294) (Fig.
1A), two deletion mutants were
designed, cloned, and overexpressed with the intent to delineate the
RNA-binding determinants within the modular protein. The first
construct, La-RRM1, was projected to be the minimal unit with specific
RNA binding activity. Previous studies had found that neither the
isolated La domain (27, 28) nor RRM1 alone (29) dispose of RNA
recognition specificity. Furthermore, high affinity RNA binding by RRM1
in conjunction with the La-specific domain was achieved only in the
presence of several subsequent C-terminal residues (28). Therefore,
La-RRM1 was chosen to span the N-terminal region of La, comprising the
La motif, amino acids 16-111, the RNA-binding domain RRM1, and 17 subsequent amino acids (185) (Fig. 1A). These amino
acids were added based on secondary structure predictions that revealed
an -helical element ending at residue 202. To investigate the
additional contributions of RRM2 to RNA affinity, a second mutant
comprising amino acids 10-300, La-RRM1-RRM2, was designed. In this
construct the putative RNA-binding region in the C-terminal domain was
included.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 1.
The domain structure in La autoantigen.
A, schematic representation of the constructs employed in
the RNA binding assays. B, analysis of the purified proteins
La, 46.8 kDa; La-RRM1, 23.7 kDa; La-RRM1-RRM2, 33.9 kDa by
Coomassie-stained SDS-PAGE. Molecular mass markers (lane
M) are indicated. C, primary and secondary structural
elements of the RRM domains in La in comparison with
Drosophila Sxl protein and the human spliceosomal protein
U1A. The RRM signature domains RNP-1 and RNP-2 are
boxed. The conserved residues involved in RNA
contacts or the domain core are shaded.
|
|
The full-length La protein and the truncation mutants were all purified
in very high yields in three steps by anion exchange, heparin, and
poly-uracil affinity chromatography. UV-visible spectra confirmed that
the recombinant protein was obtained RNA free. Coomassie Blue staining
of SDS-PAGE gels established the purity to be >95% (Fig.
1B). The identity of the proteins was confirmed by
N-terminal sequencing. Circular dichroism spectra verified that all
proteins were folded (data not shown).
Characterization of the La Complex with a Single-stranded RNA
Substrate--
Equilibrium binding titration experiments were
performed to determine the apparent dissociation constants
Kd of full-length La and the two deletion mutants
La-RRM1 and La-RRM1-RRM2. Increasing amounts of wild-type or mutant
protein were added to the nonameric RNA substrate 9nt-U, which carries
a poly-uridylate sequence at the 3' terminus to mimic the binding site
on tRNA precursors. Binding titrations for all three proteins were
carried out under identical conditions.
With increasing protein concentrations, the RNA probe was recruited to
slower migrating forms, because of specific complex formation (Fig.
2). Whereas for the La-RRM1 fragment only
one slower migrating form was identified (Fig. 2C), for
La-RRM1-RRM2 (Fig. 2B) and the full-length La (Fig.
2A) two distinct bands of retarded mobility were detected,
indicating that complexes of different oligomerization states were
formed. For quantitation of the fractions of RNA complexed by protein,
, all shifted bands were quantitated with a phosphorus imaging
device. A plot of the binding data is presented in Fig. 2D.
The versus protein concentration data were analyzed by a
nonlinear least square fit to the Langmuir equation, affording a
Kd value of 25 ± 10 nM for the full-length protein. The deletion mutant La-RRM1 binds with a 5-fold
higher affinity as witnessed by a Kd of 6 ± 3 nM, suggesting that it is a sufficient functional unit for
RNA recognition. La-RRM1-RRM2, which contains the second putative RRM
domain, binds with an ~3-4-fold lower affinity relative to the
full-length protein. The dissociation constant of this construct was
determined to be 90 ± 10 nM. All
Kd values reported are apparent dissociation
constants, with the assumption that the protein binds as a monomer
because the oligomerization state was not determined.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 2.
Binding affinity of La and the truncation
variants. Representative gel mobility shift assays of full-length
La binding (A), La-RRM1-RRM2 binding (B), and
La-RRM1 binding (C) to the 9nt-U nonamer containing the
3'-UUU-OH binding site. Increasing amounts of protein were titrated
into binding reaction mixtures containing 150 nM of
radiolabeled 9nt-U. D, results for full-length La
(open squares), La-RRM1-RRM2 (solid triangles),
and La-RRM1 (solid circles) binding to 9nt-U. The data are
plotted as the fraction of radiolabeled probe bound versus
the concentration of protein. The solid lines are the best
least squares fit to Equation 1.
|
|
Binding Specificity--
To assess the ability of La and its
truncation mutants to discriminate for the specific RNA substrate
9nt-U, the stability of a protein complex with the 9nt-U substrate was
challenged by titrating increasing amounts of unlabeled competitor into
the binding reactions prior to the addition of the specific 9nt-U substrate. Either the 9nt-U substrate or a RNA nonamer containing a
hexameric adenylate stretch at the 3'-end, 9nt-A, served as the
specific or nonspecific competitor, respectively. The competition data
were analyzed by a plot of the protein fraction bound to the specific
RNA substrate after addition of the competitor RNA versus
competitor concentration (Fig. 3). A
least squares fit of the data for La and its truncation mutants to
Equation 2 yielded Kd values for the specific
competitor probe 9nt-U in excellent agreement with those determined
with the binding titration experiments (Table
I). The binding affinity for the
nonspecific 9nt-A competitor afforded apparent dissociation constants
in the micromolar range. The relative binding affinities of the three proteins paralleled the affinities found with the specific probe, Kd(La-RRM1) > Kd(La) > Kd(La-RRM1-RRM2). Thus for all three
proteins, the binding specificity is ~100-fold (Table I).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 3.
RNA binding specificity as determined by
competition experiments. Shown are the gel mobility shift assays
of binding reactions where increasing amounts of unlabeled competitor
RNAs 9nt-U and 9nt-A were titrated into reaction mixtures containing
150 nM 32P-labeled 9nt-U substrate and 27 nM full-length La (A), 270 nM
La-RRM1-RRM2 (B), or 9 nM La-RRM1
(C). The data from one set of experiments are plotted as the
fraction bound of radiolabeled 9nt-U probe versus the
concentration of unlabeled specific competitor RNA 9nt-U (solid
triangles) or nonspecific competitor 9nt-A (open
circles).
|
|
Influence of ATP--
The basic region of human La contains the
sequence 333GRRFKGKG340 representing a
potential NTP-binding site of the consensus sequence GXXXXGKX Walker A motif found in a number of
ATP-binding proteins (23). Inconsistent results have been reported for
the RNA binding affinity of La in the presence of ATP. Although no
influence of ATP was found in filter binding assays (31), abrogation of
RNA binding in the presence of ATP was reported with immunoprecipitated complexes (30). Thus the complex stability in the presence of a 10-fold
excess of ATP was investigated under the conditions established for the
binding titration experiments described in the previous sections, and
the results of these experiments are presented in Fig.
4. The RNA binding affinity of
full-length La is maintained at 25 nM ATP. Similar results
were obtained with the nonhydrolyzable ATP mimic ATP- -S (data not
shown). An influence of ATP binding and ATP hydrolysis in mediating the
sequence-specific 3'-end recognition of RNA can thus be excluded.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Influence of ATP on the RNA binding affinity
of La. The results for La binding to the specific RNA substrate in
the presence (solid triangles) and absence (open
circles) of ATP are shown. The data are plotted as the fraction of
radiolabeled RNA probe bound versus La protein concentration
with a best least squares fit to Equation 1.
|
|
Influence of Phosphorylation--
The residue Ser366
of La resides within a conserved casein kinase II phosphorylation site
with the consensus sequence (S/T)XX(D/E) (31, 35). La
phosphorylation was found to induce a large decrease in transcriptional
activity (4, 7) that has been attributed to the decreased affinity of
the phosphorylated protein for the 5'-end in tRNA precursors (4). In an
attempt to determine the influence of phosphorylation on the 3'-end
single-stranded RNA binding affinity, recombinant human La was treated
with casein kinase II in the presence of ATP. The resulting
phosphorylation products were fractionated by one-dimensional
isoelectric focussing in a linear pH gradient (Fig.
5A). The casein kinase
treatment of the La antigen caused all of the bands to shift to more
acidic forms with one predominant species identified at pI 6.6 and two minor bands at more acidic positions (Fig. 5A). La protein
incubated under identical conditions but in the absence of enzyme
served as a control. The recombinant untreated La protein was separated into one predominant product at a pI of ~6.7 consistent with the calculated pI of 6.68 and two minor isoforms with pI values ranging from 7.0-7.4. To test whether the appearance of these isoelectric isoforms was a result of in vivo phosphorylation in E. coli, recombinant La was also treated with protein phosphatase 1 and subsequently resolved on an isoelectric focussing gel. No changes
in the gel pattern were detectable, suggesting that the formation of
additional bands was not induced by a modification in the
phosphorylation structure (data not shown). Alternatively, the
phosphatase may not be able to remove all the phosphates from the
protein.

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 5.
Phosphorylation decreases the 3'-end RNA
recognition activity of La. A, one-dimensional
isoelectric focussing gel electrophoresis of recombinant La
(La) and phosphorylated La (La-P) after casein
kinase II treatment. The positions of the pH markers (M) are
as indicated. B, recombinant La (left side) and
casein kinase II treated La (right side) were analyzed in
parallel by gel mobility shift assays with the specific RNA substrate
9nt-U. The protein concentrations employed are indicated. C,
effect of phosphorylation on the binding affinity of La. The fraction
of specific RNA substrate bound by recombinant La (solid
triangles) and phosphorylated La (open circles) were
quantitated, plotted against the protein concentration, and fit to
Equation 2.
|
|
For quantitation of the RNA binding properties, the phosphorylated
species as well as the untreated protein were subjected to binding
titration assays with the radiolabeled RNA substrate and resolved on a
native PAGE (Fig. 5B). Analysis of the fit to the binding
isotherm reproducibly revealed a Kd of ~90 ± 7 nM for the phosphorylated species versus
47 ± 2 nM for the untreated protein, accounting for a
2-fold decrease in binding affinity upon phosphorylation (Fig.
5C). The overall elevated Kd values are
likely to be a result of the extended incubation time at 30 °C
during the phosphorylation reaction. A severe decrease in binding
activity was noted when the La protein was exposed to elevated
temperatures for several weeks (data not shown).
 |
DISCUSSION |
One of the intriguing features of the La antigen is its modular
nature. The full-length protein is composed of a N-terminal and a
C-terminal domain connected by a 43-amino acid spacer that links two
RNA-binding motifs. A bipartite binding model linking 3'-oligouridylate
affinity to the N-terminal region and 5'-end RNA affinity to the
C-terminal region has been proposed (4). Our assay system was designed
to study the 3'-end poly(U) recognition specificity and to map the
contributions of the individual protein domains to this activity. It
was shown that La discriminates by 80-fold for a single-stranded
nonameric RNA probe with an oligouridylate tail over RNA with a
3'-poly(A) stretch. The high stability of the La-RNA complex is
manifested in an apparent dissociation constant (Kd) of 25 ± 10 nM,
comparable with the values of 17 nM determined for La
binding to HIV-1 TAR RNA and 23 nM obtained for U1
RNA but higher than the Kd values of 5 or 6 nM obtained for hY4 RNA and hY1 RNA, respectively (27, 28).
Because human Y RNAs contain a 5'-end triphosphate moiety, the
3-4-fold superior affinity for Y RNAs is likely a result of an
additional interaction with the 5'-end. As further evidence, an
~3-fold diminished affinity of La for tRNA precursors lacking the
5'-pppG/A nucleotide was reported (4).
In the gel shift pattern for La, a second band of lower mobility
appeared at higher protein concentrations, and protein dimerization could possibly account for the formation of this new species. In
support of this interpretation, a dimerization domain had been mapped
to the region of amino acids 294-348 (22). This domain was found to be
essential for the function of La in enhancing translation of poliovirus
RNA and HIV TAR element containing mRNAs in vitro
(22).
Contribution of the N-terminal La-RRM1 Domain to RNA Complex
Stability--
In our assay system, the La-RRM1 mutant binds with a
5-fold higher affinity to the oligouridylated RNA substrate than to
full-length La. The specificity ratio of ~120 is comparable with the
full-length protein. The results presented herein establish for the
first time quantitatively that the N-terminal domain is not only
sufficient for the binding of La to RNA, but indeed it confers sequence
specificity to the protein. In previous investigations, the recognition
activities of several RRM domains were rarely found to possess any
inherent sequence specificity and often required a second RNA-binding
domain or other auxiliary domains (18, 36). Likewise, RRM1 does not exhibit high affinity RNA binding on its own but only in conjunction with the La motif and additional C-terminal linker residues (27). It
has been suggested that the La motif could adopt a RRM fold as well
(26). Our analysis carried out with several secondary structure
prediction algorithms, as well as the CD spectra, however, revealed
predominantly -helical consensus elements in this domain, in
disagreement with a RRM topology. Conversely, the fold for the region
of amino acids 112-184 was predicted to be consistent with a RRM
domain. Thus even though the La motif and the linker residues are
likely to participate in RNA contacts, we believe that they do this in
a manner distinct from the RRM domain.
In contrast to full-length La, La-RRM1 apparently lacks the ability for
higher order complex formation, because only one distinct RNA complex
is observed in the gel shifts, consistent with a localization of the
dimerization domain in the C-terminal region of the protein. This
ability of isolated RRMs to exhibit superior binding to RNA relative to
the full-length protein has been previously witnessed. For example,
both the Sxl (sex-lethal)
protein in Drosophila melanogaster and the poly(A) binding
protein in Xenopus exhibit enhanced binding in the absence
of the C-terminal residues (37, 38). In both cases these regions were
postulated to be involved in protein-protein interactions and to
interfere with RNA binding of the full-length protein in the absence of
their physiological interaction partners. A possible candidate for an
interaction partner of La could be the Ro antigen associated with La in
hY RNA ribonucleoprotein particles (39).
Influence of La-RRM2 on RNA Complex Formation--
The sequence of
human La antigen revealed a second putative RRM in the C-terminal
domain of La (21). Secondary structure prediction algorithms identify
the elements necessary to maintain the      fold of the
RNP motif. The signature RNP-1 and RNP-2 motifs, which are usually
involved in RNA contacts, are highly degenerate, however (Fig.
1C). To investigate the contribution of RRM2 to specific
3'-end RNA recognition, another mutant was designed by adding this
motif. The results obtained with this construct were unexpected.
Addition of RRM2 reduced the RNA binding affinity in the La-RRM1-RRM2
tandem unit by about 20-fold compared with the La-RRM1 mutant.
Similarly, for a La mutant comprising amino acids 1-328, a diminished
RNA binding affinity compared with the full-length protein had been
reported previously but was not quantified (4). La-RRM1-RRM2 maintained
a specificity ratio of ~100, indicating that single-stranded RNA
recognition is generally deteriorated rather than being restricted to
3'-end poly(U) recognition.
Several factors may induce the lower affinity of La-RRM1-RRM2. For
instance, with a 43-amino acid spacer connecting the RRMs, the two
domains could be situated as much as 150 Å apart. Thus lacking any
further stabilization by the protein scaffold, the two domains may be
unfavorably positioned for RNA binding. Restoration of a 5-fold lower
Kd value in the full-length La could be interpreted
as evidence for this unfavorable orientation of the domains, although
comparison of crystal structures of bound and free forms of tandem RRM
domains indicate that RNA binding is often coupled with structural
organization and rigidification of the interdomain linkers (40-44). An
alternative explanation would thus consider participation of other
C-terminal auxiliary domains in the RNA binding affinity of La, such as
the highly basic region between amino acid 328 and 344, absent in the mutant.
Features unique to RRM2 could also induce the inferior RNA binding
affinity of La-RRM1-RRM2. The binding sites recognized by RRM domains
in the complex structures previously characterized usually extend over
2-6 bases (40, 45, 46). Assuming that the 3'-UUU-OH binding site on
RNA substrates is already occupied by the interaction with the La-RRM1
unit, RRM2 may have a RNA sequence- or structure-specific preference
not satisfied with the nonamer employed in this study. A possible role
for RRM2 could be the 5'-end stabilization in tRNA precursors (47), but
it could also contribute to the affinity for RNAs lacking the UUU-OH recognition site, including a stem-loop structure in hepatitis B virus
RNA and HIV-1 TAR RNA (27, 48). Even though the latter binding
activity was at least partially localized in RRM1, a contribution from
RRM2 cannot be excluded without additional data.
Several RRM·RNA complexes have been structurally characterized, and
they demonstrate the remarkable versatility of the RRM scaffold,
presenting an enormous repertoire of RNA-binding surfaces to
single-stranded and stem-loop RNA structures (40, 46, 49, 50). Even
though it is not possible to deduce a general RNA recognition code,
comparison of the RNP signature regions in the RRM domains of La,
Drosophila Sxl, and U1A spliceosomal protein, allows for
identification of several features that might explain the poor RNA
binding affinity of the La-RRM2 (Fig. 1A). Most strikingly, RRM2 contains Glu residues in the RNP-1 motif at the conserved positions 279 and 286, which are usually occupied by a positively charged Lys or Arg residue involved in RNA backbone interactions and an
aromatic Phe/Tyr residue, respectively. In analogy, a negatively charged residue at the position equivalent to 279 also occurs in RRM1
of the apoptotic death signaling protein TIA-1, which does not exhibit
any RNA binding activity (51). Furthermore, based on an inspection of
the known RRM structures, amino acid types of Tyr114 in
RNP-2 and Phe155 in RNP-1 are, as part of a solvent-exposed
hydrophobic patch, conserved among RNP proteins. These residues engage
in aromatic stacking interactions with the RNA bases and presumably
attribute largely to the free energy of binding. Small aliphatic Cys or Leu residues replace the equivalent residues in the La-RRM-2. The
diminished number of aromatic stacking contacts in the RNA-binding regions could perhaps lead to the low RNA binding affinity in La-RRM2.
Conversely, the polar or charged Asn or Lys residue at position 116 in
RNP-2, involved in a base specific contact in the other proteins, is
replaced by the sequence-neutral Leu residue in La-RRM2. From a
combination of all these interactions, it seems that La-RRM1 contains a
reasonably well conserved RNP domain, whereas the diminished RNA
binding properties of RRM2 are likely a result of its divergent amino
acid sequence.
A difference in the nature of the complexes formed by La-RRM1-RRM2
versus the La-RRM1 mutant is observed in the gel retardation assays. In contrast to La-RRM1, the gel shift pattern reveals two
distinct bands, indicating that the ability to form a second defined
complex as observed in the full-length protein is restored through the
addition of RRM2. Protein-protein interactions could occur through
RRM2, but the dimerization domain in the region of residues 294-348
may be required for high affinity interaction. As further evidence, the
RRM domain of the spliceosomal protein U2B" binds to its cognate RNA
only in the presence of U2A'. This protein-protein interaction occurs
through the RRM domain (49, 52).
Influence of the Other C-terminal Domains in 3'-End
Recognition--
Several lines of evidence in this study suggest that
apart from RRM2 other domains in the C-terminal region of La also
influence the 3'-end affinity of the protein. The increased complex
stability observed with full-length protein over the La-RRM1-RRM2
variant indirectly indicates a contribution of the regions further
downstream to RRM2. Phosphorylation of La Ser366 had been
suggested to represent a control mechanism in the 5'-end processing
events of tRNA precursors, because it abrogates the protection activity
for these substrates. Binding experiments in this study showed that the
3'-end interaction is also affected through phosphorylation, indicated
by a 2-fold decrease in binding activity compared with the
unphosphorylated protein. A similar decrease was reported under
nonequilibrium conditions in a filter binding assay (31). Whether
regulation through modification of Ser366 occurs strictly
because of a change in charge distribution or whether conformational
changes are involved remains to be determined. In contrast to another
report (30), no influence of ATP or ATP- -S on 3'-end RNA recognition
was detected. Indeed, recent results indicate that the Walker A motif
is more likely to be involved in recognition of the 5'-ppp terminus of
nascent tRNA transcripts (4). Such a role would be consistent with our
data because it does not interfere with the 3'-UUU-OH binding activity
of the protein and is not detected in our assay.
Functional Implications--
By binding to the UUU-OH 3'-end motif
of RNA polymerase III synthesized RNA, La stabilizes the precursor
forms of these transcripts (26). Further processing of nascent RNA
involves 3'- and 5'-end metabolism (53). Increasing evidence becomes
available that La is integrating activities controlling both events,
which had been roughly mapped to the N- and C-terminal regions of the
protein, respectively (4, 47). This study provides a systematic
quantitative analysis of the affinity and specificity of La variants
for the 3'-poly(U) tail and shows that both protein regions contribute either positively or negatively to this activity. The N-terminal domain
comprising amino acids 1-200 was shown to be the functional unit for
recognition of the 3'-poly(U) transcription termination signal. The
superior affinity and specificity of this domain for the
oligouridylated RNA, combined with the fact that it is the most highly
conserved part of the protein, suggests that this part of the protein
has evolved for 3'-end binding. The lower Kd value
for RNA binding upon addition of the RRM2 points to a different target
for this domain, consistent with the proposal that RRM2 may recognize a
distinct determinant at the 5'-end of the nascent RNA polymerase III
RNA (47). Furthermore, it can be concluded from our results that in
contrast to the bipartite binding hypothesis, the C-terminal auxiliary
domains are involved in both 3'- and 5'-end processing.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Robert Huber for generous
support. We thank Dr. Ger J. M. Pruijn (University of Nijmegen,
Nijmegen, The Netherlands) for providing the La/SS-B expression plasmid
and Dr. Karl-Heinz Mann (Max-Planck-Institut für Biochemie,
Martinsried) for protein sequencing. We gratefully acknowledge Dr. F. Ulrich Hartl, Dr. Manajit Hayer-Hartl, and co-workers for giving us
access to their isotope laboratories and equipment. We are indebted to
Andrea Papendorf for experimental assistance and to Elizabeth Weyher for recording the CD spectra.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed:
Max-Planck-Institut für Biochemie, Abteilung Strukturforschung,
Am Klopferspitz 18a, D-82152 Planegg-Martinsried, Germany. Fax:
49-89-8578-3516; E-mail: ohndorf@biochem.mpg.de.
Published, JBC Papers in Press, May 7, 2001, DOI 10.1074/jbc.M102891200
 |
ABBREVIATIONS |
The abbreviations used are:
RRM, RNA recognition
motif;
RNP, ribonucleoprotein;
ATP- -S, adenosine
5'-O-(thiotriphosphate);
PAGE, polyacrylamide gel
electrophoresis;
HIV, human immunodeficiency virus;
TAR, Tat responsive
element.
 |
REFERENCES |
| 1.
|
Mattioli, M.,
and Reichlin, M.
(1974)
Arthritis Rheum.
17,
421-429
|
| 2.
|
Stefano, J. E.
(1984)
Cell
36,
145-154
|
| 3.
|
Pannone, B. K.,
Xue, D. H.,
and Wolin, S. L.
(1998)
EMBO J.
17,
7442-7453
|
| 4.
|
Fan, H.,
Goodier, J. L.,
Chamberlain, J. R.,
Engelke, D. R.,
and Maraia, R. J.
(1998)
Mol. Cell. Biol.
18,
3201-3211
|
| 5.
|
Gottlieb, E.,
and Steitz, J. A.
(1989)
EMBO J.
8,
851-861
|
| 6.
|
Maraia, R. J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3383-3387
|
| 7.
|
Fan, H.,
Sakulich, A. L.,
Goodier, J. L.,
Zhang, X. L.,
Qin, J.,
and Maraia, R. J.
(1997)
Cell
88,
707-715
|
| 8.
|
Maraia, R. J.,
Kenan, D. J.,
and Keene, J. D.
(1994)
Mol. Cell. Biol.
14,
2147-2158
|
| 9.
|
Bachmann, M.,
Pfeifer, K.,
Schröder, H. C.,
and Müller, W. E. G.
(1990)
Cell
60,
85-93
|
| 10.
|
Hühn, P.,
Pruijn, G. J. M.,
van Venrooij, W. J.,
and Bachmann, M.
(1997)
Nucleic Acids Res.
25,
410-416
|
| 11.
|
James, M. C.,
Jeffrey, I. W.,
Pruijn, G. J. M.,
Thijssen, J. P. H.,
and Clemens, M. J.
(1999)
Eur. J. Biochem.
266,
151-162
|
| 12.
|
Ali, N.,
and Siddiqui, A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2249-2254
|
| 13.
|
McLaren, R. S.,
Caruccio, N.,
and Ross, J.
(1997)
Mol. Cell. Biol.
17,
3028-3036
|
| 14.
|
Chambers, J. C.,
Kenan, D.,
Martin, B. J.,
and Keene, J. D.
(1988)
J. Biol. Chem.
263,
18043-18051
|
| 15.
|
Varani, G.,
and Nagai, K.
(1998)
Annu. Rev. Biophys. Biomol. Struct.
27,
407-445
|
| 16.
|
Chan, E. K. L.,
Sullivan, K. F.,
Fox, R. I.,
and Tan, E. M.
(1989)
J. Autoimmun.
2,
321-327
|
| 17.
|
Sobel, S. G.,
and Wolin, S. L.
(1999)
Mol. Biol. Cell
10,
3849-3862
|
| 18.
|
Query, C. C.,
Bentley, R. C.,
and Keene, J. D.
(1989)
Cell
57,
89-101
|
| 19.
|
Pruijn, G. J. M.,
Thijssen, J. P. H.,
Smith, P. R.,
Williams, D. G.,
and van Venrooij, W. J.
(1995)
Eur. J. Biochem.
232,
611-619
|
| 20.
|
van Venrooij, W. J.,
Slobbe, R. L.,
and Pruijn, G. J. M.
(1993)
Mol. Biol. Reports
18,
113-119
|
| 21.
|
Birney, E.,
Kumar, S.,
and Krainer, A. R.
(1993)
Nucleic Acids Res.
21,
5803-5816
|
| 22.
|
Craig, A. W. B.,
Svitkin, Y. V.,
Lee, H. S.,
Belsham, G. J.,
and Sonenberg, N.
(1997)
Mol. Cell. Biol.
17,
163-169
|
| 23.
|
Topfer, F.,
Gordon, T.,
and McCluskey, J.
(1993)
J. Immunol.
150,
3091-3100
|
| 24.
|
Rosenblum, J. S.,
Pemberton, L. F.,
Bonifaci, N.,
and Blobel, G.
(1998)
J. Cell Biol.
143,
887-899
|
| 25.
|
Simons, F. H. M.,
Broers, F. J. M.,
Van Venrooij, W. J.,
and Pruijn, G. J. M.
(1996)
Exp. Cell Res.
224,
224-236
|
| 26.
|
Maraia, R. J.,
and Intine, R. V. A.
(2001)
Mol. Cell. Biol.
21,
367-379
|
| 27.
|
Chang, Y. N.,
Kenan, D. J.,
Keene, J. D.,
Gatignol, A.,
and Jeang, K. T.
(1994)
J. Virol.
68,
7008-7020
|
| 28.
|
Goodier, J. L.,
Fan, H.,
and Maraia, R. J.
(1997)
Mol. Cell. Biol.
17,
5823-5832
|
| 29.
|
Pruijn, G. J. M.,
Slobbe, R. L.,
and van Venrooij, W. J.
(1991)
Nucleic Acids Res.
19,
5173-5180
|
| 30.
|
Bachmann, M.,
Schröder, H. C.,
Wagner, K. G.,
Mayet, W. J.,
Pfeifer, K.,
and Müller, W. E. G.
(1986)
Biol. Chem. Hoppe-Seyler
367,
671-680
|
| 31.
|
Pfeifle, J.,
Anderer, F. A.,
and Franke, M.
(1987)
Biochim. Biophys. Acta
928,
217-226
|
| 32.
|
Lohman, T. M.,
and Mascott, D. P.
(1992)
Methods Enzymol.
212,
400-424
|
| 33.
|
Lin, S.-Y.,
and Riggs, A. D.
(1972)
J. Mol. Biol.
72,
671-690
|
| 34.
|
Mathews, M. B.,
and Francoeur, A. M.
(1984)
Mol. Cell. Biol.
4,
1134-1140
|
| 35.
|
Pizer, L. I., J.-S., D.,
Stenberg, R. M.,
and Tan, E. M.
(1983)
Mol. Cell. Biol.
3,
1235-1245
|
| 36.
|
Görlach, M.,
Burd, C. G.,
and Dreyfuss, G.
(1994)
J. Biol. Chem.
269,
23074-23078
|
| 37.
|
Kanaar, R.,
Lee, A. L.,
Rudner, D. Z.,
Wemmer, D. E.,
and Rio, D. C.
(1995)
EMBO J.
14,
4530-4539
|
| 38.
|
Kühn, U.,
and Pieler, T.
(1996)
J. Mol. Biol.
256,
20-30
|
| 39.
|
Scofield, R. H.,
Kurien, B. T.,
Zhang, F.,
Mehta, P.,
Kaufman, K.,
Gross, T.,
Bachmann, M.,
Gordon, T.,
and Harley, J. B.
(1999)
Mol. Immunol.
36,
1093-1106
|
| 40.
|
Handa, N.,
Nureki, O.,
Kurimoto, K.,
Kim, I.,
Sakamoto, H.,
Shimura, Y.,
Muto, Y.,
and Yokoyama, S.
(1999)
Nature
398,
579-585
|
| 41.
|
Shamoo, Y.,
Krueger, U.,
Rice, L. M.,
Williams, K. R.,
and Steitz, T. A.
(1997)
Nat. Struct. Biol.
4,
215-222
|
| 42.
|
Ding, J. Z.,
Hayashi, M. K.,
Zhang, Y.,
Manche, L.,
Krainer, A. R.,
and Xu, R. M.
(1999)
Genes Dev.
13,
1102-1115
|
| 43.
|
Crowder, S. M.,
Kanaar, R.,
Rio, D. C.,
and Alber, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4892-4897
|
| 44.
|
Xu, R. M.,
Jokhan, L.,
Cheng, X. D.,
Mayeda, A.,
and Krainer, A. R.
(1997)
Structure
5,
559-570
|
| 45.
|
Allain, F. H. T.,
Bouvet, P.,
Dieckmann, T.,
and Feigon, J.
(2000)
EMBO J.
19,
6870-6881
|
| 46.
|
Deo, R. C.,
Bonanno, J. B.,
Sonenberg, N.,
and Burley, S. K.
(1999)
Cell
98,
835-845
|
| 47.
|
Intine, R. V. A.,
Sakulich, A. L.,
Koduru, S. B.,
Huang, Y.,
Pierstorff, E.,
Goodier, J. L.,
Phan, L.,
and Maraia, R. J.
(2000)
Mol. Cell
6,
339-348
|
| 48.
|
Heise, T.,
Guidotti, L. G.,
and Chisari, F. V.
(1999)
J. Virol.
73,
5767-5776
|
| 49.
|
Price, S. R.,
Evens, P. R.,
and Nagai, K.
(1998)
Nature
394,
645-650
|
| 50.
|
Oubridge, C.,
Ito, N.,
Evans, P. R.,
Teo, C. H.,
and Nagai, K.
(1994)
Nature
372,
432-438
|
| 51.
|
Dember, L. M.,
Kim, N. D.,
Liu, K. Q.,
and Anderson, P.
(1996)
J. Biol. Chem.
271,
2783-2788
|
| 52.
|
Scherly, D.,
Dathan, N. A.,
Boelens, W.,
van Venrooij, W. J.,
and Mattaj, I. W.
(1990)
EMBO J.
9,
3675-3681
|
| 53.
|
Wolin, S. L.,
and Matera, A. G.
(1999)
Genes Dev.
13,
1-10
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Mondal, U. Ray, A. K. Manna, R. Gupta, S. Roy, and S. Das
Structural Determinant of Human La Protein Critical for Internal Initiation of Translation of Hepatitis C Virus RNA
J. Virol.,
December 1, 2008;
82(23):
11927 - 11938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nykamp, M.-H. Lee, and J. Kimble
C. elegans La-related protein, LARP-1, localizes to germline P bodies and attenuates Ras-MAPK signaling during oogenesis
RNA,
July 1, 2008;
14(7):
1378 - 1389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. O'Connor and K. Collins
A Novel RNA Binding Domain in Tetrahymena Telomerase p65 Initiates Hierarchical Assembly of Telomerase Holoenzyme.
Mol. Cell. Biol.,
March 1, 2006;
26(6):
2029 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Huang, J. Hwang, S. D. Sharma, M. R. S. Hargittai, Y. Chen, J. J. Arnold, K. D. Raney, and C. E. Cameron
Hepatitis C Virus Nonstructural Protein 5A (NS5A) Is an RNA-binding Protein
J. Biol. Chem.,
October 28, 2005;
280(43):
36417 - 36428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Brenet, N. Dussault, J. Borch, G. Ferracci, C. Delfino, P. Roepstorff, R. Miquelis, and L. Ouafik
Mammalian Peptidylglycine {alpha}-Amidating Monooxygenase mRNA Expression Can Be Modulated by the La Autoantigen
Mol. Cell. Biol.,
September 1, 2005;
25(17):
7505 - 7521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. Intine, M. Dundr, A. Vassilev, E. Schwartz, Y. Zhao, Y. Zhao, M. L. DePamphilis, and R. J. Maraia
Nonphosphorylated Human La Antigen Interacts with Nucleolin at Nucleolar Sites Involved in rRNA Biogenesis
Mol. Cell. Biol.,
December 15, 2004;
24(24):
10894 - 10904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Horke, K. Reumann, C. Schulze, F. Grosse, and T. Heise
The La Motif and the RNA Recognition Motifs of Human La Autoantigen Contribute Individually to RNA Recognition and Subcellular Localization
J. Biol. Chem.,
November 26, 2004;
279(48):
50302 - 50309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Schwartz, R. V. Intine, and R. J. Maraia
CK2 Is Responsible for Phosphorylation of Human La Protein Serine-366 and Can Modulate rpL37 5'-Terminal Oligopyrimidine mRNA Metabolism
Mol. Cell. Biol.,
November 1, 2004;
24(21):
9580 - 9591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hino, T. Suzuki, T. Yasukawa, K. Seio, K. Watanabe, and T. Ueda
The pathogenic A4269G mutation in human mitochondrial tRNAIle alters the T-stem structure and decreases the binding affinity for elongation factor Tu
Genes Cells,
March 1, 2004;
9(3):
243 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tanabe, N. Ito, T. Wakuri, F. Ozoe, M. Umeda, S. Katayama, K. Tanaka, H. Matsuda, and M. Kawamukai
Sla1, a Schizosaccharomyces pombe Homolog of the Human La Protein, Induces Ectopic Meiosis when Its C Terminus Is Truncated
Eukaryot. Cell,
December 1, 2003;
2(6):
1274 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pudi, S. Abhiman, N. Srinivasan, and S. Das
Hepatitis C Virus Internal Ribosome Entry Site-mediated Translation Is Stimulated by Specific Interaction of Independent Regions of Human La Autoantigen
J. Biol. Chem.,
March 28, 2003;
278(14):
12231 - 12240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Horke, K. Reumann, A. Rang, and T. Heise
Molecular Characterization of the Human La Protein{middle dot}Hepatitis B Virus RNA.B Interaction in Vitro
J. Biol. Chem.,
September 13, 2002;
277(38):
34949 - 34958.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|